FRIEDMAN CATHY

LYEL

FRIEDMAN CATHY serves as Director at Lyell Immunopharma, Inc. (LYEL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$300.0K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$300.0K

Companies Traded

LYEL

Active Period

Jun 2021

1 total trades

Most Recent

Buy LYEL

Jun 23, 2021 · $300.0K

FRIEDMAN CATHY's Insider Trading at Lyell Immunopharma, Inc. (LYEL)

Buys

1 · $300.0K

Sells

0 · $0.00

Total Shares Bought

17,648

Total Shares Sold

LYEL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 23, 2021	Buy	17,648	$17.00	$300.0K	17,648

Related Insiders

David Shook

officer: Chief Medical Officer

LYELSell · Jun 11, 2026

ARCH Venture Partners IX, LLC

10 percent owner

LYELBuy · Mar 9, 2026

ARCH Venture Fund XIII, L.P.

10 percent owner

LYELBuy · Mar 9, 2026

Stephen J. Hill

Chief Operating Officer

LYELSell · Feb 11, 2026

Gary K. Lee

Chief Scientific Officer

LYELSell · Feb 11, 2026

Lynn Seely

President and CEO

LYELSell · Feb 11, 2026

Veronica Sanchez Bulis

VP, Corporate Controller

LYELSell · Feb 10, 2026

Charles W. Newton

Chief Financial Officer

LYELSell · Aug 20, 2025

Explore More Insider Trading Data

LYEL Insider Trading Activity

View all insider trades at Lyell Immunopharma, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity